Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 99

    1.

    Risk factors of osteopenia in HIV-infected women: No role of antiretroviral therapy.

    Libois A, Clumeck N, Kabeya K, Gerard M, De Wit S, Poll B, Tondeur M, Rozenberg S.

    Maturitas. 2009 Nov 23. [Epub ahead of print]PMID: 19939594 [PubMed - as supplied by publisher]

    2.

    Sustained HIV RNA suppression after switching from enfuvirtide to etravirine in the early access programme.

    Loutfy M, Ribera E, Florence E, De Wit S, Castagna A, Ryan R, Hill A, Vanaken H, van Delft Y, Marks S.

    J Antimicrob Chemother. 2009 Dec;64(6):1341-4. Epub 2009 Oct 14. No abstract available. PMID: 19828488 [PubMed - in process]Related articles

    3.

    Differential engagement of the ventromedial prefrontal cortex by goal-directed and habitual behavior toward food pictures in humans.

    de Wit S, Corlett PR, Aitken MR, Dickinson A, Fletcher PC.

    J Neurosci. 2009 Sep 9;29(36):11330-8.PMID: 19741139 [PubMed - indexed for MEDLINE]Related articles

    4.

    Frontal-striatal abnormalities underlying behaviours in the compulsive-impulsive spectrum.

    den Heuvel OA, der Werf YD, Verhoef KM, de Wit S, Berendse HW, Wolters EC, Veltman DJ, Groenewegen HJ.

    J Neurol Sci. 2009 Sep 1. [Epub ahead of print]PMID: 19729172 [PubMed - as supplied by publisher]Related articles

    5.

    Resolution of conflict between goal-directed actions: outcome encoding and neural control processes.

    de Wit S, Ostlund SB, Balleine BW, Dickinson A.

    J Exp Psychol Anim Behav Process. 2009 Jul;35(3):382-93.PMID: 19594283 [PubMed - indexed for MEDLINE]Related articles

    6.

    Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection.

    Reuse S, Calao M, Kabeya K, Guiguen A, Gatot JS, Quivy V, Vanhulle C, Lamine A, Vaira D, Demonte D, Martinelli V, Veithen E, Cherrier T, Avettand V, Poutrel S, Piette J, de Launoit Y, Moutschen M, Burny A, Rouzioux C, De Wit S, Herbein G, Rohr O, Collette Y, Lambotte O, Clumeck N, Van Lint C.

    PLoS One. 2009 Jun 30;4(6):e6093.PMID: 19564922 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Associative theories of goal-directed behaviour: a case for animal-human translational models.

    de Wit S, Dickinson A.

    Psychol Res. 2009 Jul;73(4):463-76. Epub 2009 Apr 7. Review.PMID: 19350272 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Clinical value of FDG-PET/CT for the diagnosis of human immunodeficiency virus-associated fever of unknown origin: a retrospective study.

    Castaigne C, Tondeur M, de Wit S, Hildebrand M, Clumeck N, Dusart M.

    Nucl Med Commun. 2009 Jan;30(1):41-7.PMID: 19306513 [PubMed - indexed for MEDLINE]Related articles

    9.

    Evolution of genotypic resistance to enfuvirtide in HIV-1 isolates from different group M subtypes.

    Covens K, Kabeya K, Schrooten Y, Dekeersmaeker N, Van Wijngaerden E, Vandamme AM, De Wit S, Van Laethem K.

    J Clin Virol. 2009 Apr;44(4):325-8. Epub 2009 Feb 23.PMID: 19237313 [PubMed - indexed for MEDLINE]Related articles

    10.

    Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).

    Worm SW, De Wit S, Weber R, Sabin CA, Reiss P, El-Sadr W, Monforte AD, Kirk O, Fontas E, Dabis F, Law MG, Lundgren JD, Friis-Møller N.

    Circulation. 2009 Feb 17;119(6):805-11. Epub 2009 Feb 2.PMID: 19188509 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study.

    Worm SW, Sabin CA, Reiss P, El-Sadr W, Monforte A, Pradier C, Thiebaut R, Law M, Rickenbach M, De Wit S, Lundgren JD, Friis-Møller N.

    Diabetes Care. 2009 Mar;32(3):474-80. Epub 2008 Dec 3.PMID: 19056612 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

    Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Neuhaus J, Nixon D, Paton NI, Neaton JD; INSIGHT SMART Study Group.

    PLoS Med. 2008 Oct 21;5(10):e203.PMID: 18942885 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.

    Monforte A, Abrams D, Pradier C, Weber R, Reiss P, Bonnet F, Kirk O, Law M, De Wit S, Friis-Møller N, Phillips AN, Sabin CA, Lundgren JD; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group.

    AIDS. 2008 Oct 18;22(16):2143-53.PMID: 18832878 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction.

    Data Collection on Adverse Events of Anti-HIV Drugs Study Group, Sabin CA, d'Arminio Monforte A, Friis-Moller N, Weber R, El-Sadr WM, Reiss P, Kirk O, Mercie P, Law MG, De Wit S, Pradier C, Phillips AN, Lundgren JD.

    Clin Infect Dis. 2008 Apr 1;46(7):1101-10.PMID: 18461712 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.

    D:A:D Study Group, Sabin CA, Worm SW, Weber R, Reiss P, El-Sadr W, Dabis F, De Wit S, Law M, D'Arminio Monforte A, Friis-Møller N, Kirk O, Pradier C, Weller I, Phillips AN, Lundgren JD.

    Lancet. 2008 Apr 26;371(9622):1417-26. Epub 2008 Apr 2. Erratum in: Lancet. 2008 Jul 26;372(9635):292. PMID: 18387667 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006.

    Vercauteren J, Derdelinckx I, Sasse A, Bogaert M, Ceunen H, De Roo A, De Wit S, Deforche K, Echahidi F, Fransen K, Goffard JC, Goubau P, Goudeseune E, Yombi JC, Lacor P, Liesnard C, Moutschen M, Pierard D, Rens R, Schrooten Y, Vaira D, van den Heuvel A, van der Gucht B, van Ranst M, van Wijngaerden E, Vandercam B, Vekemans M, Verhofstede C, Clumeck N, Vandamme AM, van Laethem K.

    AIDS Res Hum Retroviruses. 2008 Mar;24(3):355-62.PMID: 18327983 [PubMed - indexed for MEDLINE]Related articles

    17.

    Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.

    De Wit S, Sabin CA, Weber R, Worm SW, Reiss P, Cazanave C, El-Sadr W, Monforte A, Fontas E, Law MG, Friis-Møller N, Phillips A; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.

    Diabetes Care. 2008 Jun;31(6):1224-9. Epub 2008 Feb 11.PMID: 18268071 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV.

    Lundgren JD, Battegay M, Behrens G, De Wit S, Guaraldi G, Katlama C, Martinez E, Nair D, Powderly WG, Reiss P, Sutinen J, Vigano A; EACS Executive Committee.

    HIV Med. 2008 Feb;9(2):72-81.PMID: 18257770 [PubMed - indexed for MEDLINE]Related articles

    19.

    A field study on the significance of vaccination against infectious bursal disease virus (IBDV) at the optimal time point in broiler flocks with maternally derived IBDV antibodies.

    Block H, Meyer-Block K, Rebeski DE, Scharr H, de Wit S, Rohn K, Rautenschlein S.

    Avian Pathol. 2007 Oct;36(5):401-9.PMID: 17899465 [PubMed - indexed for MEDLINE]Related articles

    20.

    Class of antiretroviral drugs and the risk of myocardial infarction.

    DAD Study Group, Friis-Møller N, Reiss P, Sabin CA, Weber R, Monforte A, El-Sadr W, Thiébaut R, De Wit S, Kirk O, Fontas E, Law MG, Phillips A, Lundgren JD.

    N Engl J Med. 2007 Apr 26;356(17):1723-35.PMID: 17460226 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Stimulus-outcome interactions during instrumental discrimination learning by rats and humans.

    de Wit S, Niry D, Wariyar R, Aitken MR, Dickinson A.

    J Exp Psychol Anim Behav Process. 2007 Jan;33(1):1-11.PMID: 17227190 [PubMed - indexed for MEDLINE]Related articles

    22.

    Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study.

    Weber R, Sabin CA, Friis-Møller N, Reiss P, El-Sadr WM, Kirk O, Dabis F, Law MG, Pradier C, De Wit S, Akerlund B, Calvo G, Monforte A, Rickenbach M, Ledergerber B, Phillips AN, Lundgren JD.

    Arch Intern Med. 2006 Aug 14-28;166(15):1632-41.PMID: 16908797 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    HIV and syphilis: when to perform a lumbar puncture.

    Libois A, De Wit S, Poll B, Garcia F, Florence E, Del Rio A, Sanchez P, Negredo E, Vandenbruaene M, Gatell JM, Clumeck N.

    Sex Transm Dis. 2007 Mar;34(3):141-4.PMID: 16865051 [PubMed - indexed for MEDLINE]Related articles

    24.

    Dorsomedial prefrontal cortex resolves response conflict in rats.

    de Wit S, Kosaki Y, Balleine BW, Dickinson A.

    J Neurosci. 2006 May 10;26(19):5224-9.PMID: 16687514 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study.

    Law MG, Friis-Møller N, El-Sadr WM, Weber R, Reiss P, D'Arminio Monforte A, Thiébaut R, Morfeldt L, De Wit S, Pradier C, Calvo G, Kirk O, Sabin CA, Phillips AN, Lundgren JD; D:A:D Study Group.

    HIV Med. 2006 May;7(4):218-30.PMID: 16630034 [PubMed - indexed for MEDLINE]Related articles

    26.

    Predictors of hypertension and changes of blood pressure in HIV-infected patients.

    Thiébaut R, El-Sadr WM, Friis-Møller N, Rickenbach M, Reiss P, Monforte AD, Morfeldt L, Fontas E, Kirk O, De Wit S, Calvo G, Law MG, Dabis F, Sabin CA, Lundgren JD; Data Collection of Adverse events of anti-HIV Drugs Study Group.

    Antivir Ther. 2005;10(7):811-23. Erratum in: Antivir Ther. 2005;10(8):969. PMID: 16315369 [PubMed - indexed for MEDLINE]Related articles

    27.

    Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?

    Mocroft A, Soriano V, Rockstroh J, Reiss P, Kirk O, de Wit S, Gatell J, Clotet B, Phillips AN, Lundgren JD; EuroSIDA Study Group.

    AIDS. 2005 Dec 2;19(18):2117-25.PMID: 16284461 [PubMed - indexed for MEDLINE]Related articles

    28.

    [Treatment for HIV infection: 2005 recommendations]

    De Wit S.

    Rev Med Brux. 2005 Sep;26(4):S378-81. French. PMID: 16240890 [PubMed - indexed for MEDLINE]Related articles

    29.

    Use of hydroxyurea in heavily pretreated patients with HIV infection.

    Hermans P, De Wit S, Sommereijns B, O'Doherty E, Clumeck N.

    Antivir Ther. 1999;4 Suppl 3:19-22.PMID: 16021867 [PubMed - indexed for MEDLINE]Related articles

    30.

    Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort.

    Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, Katlama C, Zilmer K, Vella S, Kirk O, Lundgren JD; EuroSIDA Group.

    AIDS. 2005 Mar 24;19(6):593-601.PMID: 15802978 [PubMed - indexed for MEDLINE]Related articles

    31.

    Indinavir/ritonavir-based therapy in HIV-1-infected antiretroviral therapy-naive patients: comparison of 800/100 mg and 400/100 mg twice daily.

    Konopnicki D, De Wit S, Poll B, Crommentuyn K, Huitema A, Clumeck N.

    HIV Med. 2005 Jan;6(1):1-6.PMID: 15670245 [PubMed - indexed for MEDLINE]Related articles

    32.

    A genotypic resistance assay for the detection of drug resistance in the human immunodeficiency virus type 1 envelope gene.

    Van Laethem K, Schrooten Y, Lemey P, Van Wijngaerden E, De Wit S, Van Ranst M, Vandamme AM.

    J Virol Methods. 2005 Jan;123(1):25-34.PMID: 15582695 [PubMed - indexed for MEDLINE]Related articles

    33.

    Viral load and CD4 cell response to protease inhibitor-containing regimens in subtype B versus non-B treatment-naive HIV-1 patients.

    De Wit S, Boulmé R, Poll B, Schmit JC, Clumeck N.

    AIDS. 2004 Nov 19;18(17):2330-1.PMID: 15577548 [PubMed - indexed for MEDLINE]Related articles

    34.

    Current levels of drug resistance among therapy-naive HIV-infected patients have significant impact on treatment response.

    Derdelinckx I, Van Laethem K, Maes B, Schrooten Y, De Wit S, Florence E, Fransen K, Ribas SG, Marissens D, Moutschen M, Vaira D, Zissis G, Van Ranst M, Van Wijngaerden E, Vandamme AM.

    J Acquir Immune Defic Syndr. 2004 Dec 15;37(5):1664-6. No abstract available. PMID: 15577426 [PubMed - indexed for MEDLINE]Related articles

    35.

    Cardio- and cerebrovascular events in HIV-infected persons.

    d'Arminio A, Sabin CA, Phillips AN, Reiss P, Weber R, Kirk O, El-Sadr W, De Wit S, Mateu S, Petoumenos K, Dabis F, Pradier C, Morfeldt L, Lundgren JD, Friis-Møller N; Writing Committee of the D:A:D: Study Group.

    AIDS. 2004 Sep 3;18(13):1811-7.PMID: 15316342 [PubMed - indexed for MEDLINE]Related articles

    36.

    Rising prevalence of HIV-1 non-B subtypes in Belgium: 1983-2001.

    Snoeck J, Van Laethem K, Hermans P, Van Wijngaerden E, Derdelinckx I, Schrooten Y, van de Vijver DA, De Wit S, Clumeck N, Vandamme AM.

    J Acquir Immune Defic Syndr. 2004 Mar 1;35(3):279-85.PMID: 15076243 [PubMed - indexed for MEDLINE]Related articles

    37.

    Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?

    Fontas E, van Leth F, Sabin CA, Friis-Møller N, Rickenbach M, d'Arminio Monforte A, Kirk O, Dupon M, Morfeldt L, Mateu S, Petoumenos K, El-Sadr W, de Wit S, Lundgren JD, Pradier C, Reiss P; D:A:D Study Group.

    J Infect Dis. 2004 Mar 15;189(6):1056-74. Epub 2004 Mar 2.PMID: 14999610 [PubMed - indexed for MEDLINE]Related articles

    38.

    Combination antiretroviral therapy and the risk of myocardial infarction.

    Friis-Møller N, Sabin CA, Weber R, d'Arminio Monforte A, El-Sadr WM, Reiss P, Thiébaut R, Morfeldt L, De Wit S, Pradier C, Calvo G, Law MG, Kirk O, Phillips AN, Lundgren JD; Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group.

    N Engl J Med. 2003 Nov 20;349(21):1993-2003. Erratum in: N Engl J Med. 2004 Feb 26;350(9):955. PMID: 14627784 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Performance of the VERSANT HIV-1 resistance assays (LiPA) for detecting drug resistance in therapy-naive patients infected with different HIV-1 subtypes.

    Derdelinckx I, Van Laethem K, Maes B, Schrooten Y, De Schouwer K, De Wit S, Fransen K, García Ribas S, Moutschen M, Vaira D, Zissis G, Van Ranst M, Van Wijngaerden E, Vandamme AM.

    FEMS Immunol Med Microbiol. 2003 Nov 28;39(2):119-24.PMID: 14625094 [PubMed - indexed for MEDLINE]Related articles

    40.

    Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.

    Friis-Møller N, Weber R, Reiss P, Thiébaut R, Kirk O, d'Arminio Monforte A, Pradier C, Morfeldt L, Mateu S, Law M, El-Sadr W, De Wit S, Sabin CA, Phillips AN, Lundgren JD; DAD study group.

    AIDS. 2003 May 23;17(8):1179-93.PMID: 12819520 [PubMed - indexed for MEDLINE]Related articles

    41.

    The interaction between discriminative stimuli and outcomes during instrumental learning.

    Dickinson A, de Wit S.

    Q J Exp Psychol B. 2003 Feb;56(1):127-39.PMID: 12623543 [PubMed - indexed for MEDLINE]Related articles

    42.

    Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) study.

    Law M, Friis-Møller N, Weber R, Reiss P, Thiebaut R, Kirk O, d'Arminio Monforte A, Pradier C, Morfeldt L, Calvo G, El-Sadr W, De Wit S, Sabin CA, Lundgren JD; DAD Study Group.

    HIV Med. 2003 Jan;4(1):1-10.PMID: 12534953 [PubMed - indexed for MEDLINE]Related articles

    43.

    Behavioral and neuroanatomical characterization of the Fmr1 knockout mouse.

    Mineur YS, Sluyter F, de Wit S, Oostra BA, Crusio WE.

    Hippocampus. 2002;12(1):39-46.PMID: 11918286 [PubMed - indexed for MEDLINE]Related articles

    44.

    Commentary on the summary of the French Guidelines for the treatment of HIV-infected adults with antiretroviral therapy.

    De Wit S.

    HIV Med. 2000 Jul;1(3):132. No abstract available. PMID: 11737338 [PubMed - indexed for MEDLINE]Related articles

    45.

    Acute pulmonary hypertension following paclitaxel in a patient with AIDS-related primary effusion lymphoma.

    Cherifi S, Hermans P, De Wit S, Cantinieaux B, Clumeck N.

    Clin Microbiol Infect. 2001 May;7(5):277-8. No abstract available. PMID: 11422257 [PubMed - indexed for MEDLINE]Related articles

    46.

    Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya.

    Moore E, O'Flaherty D, Heuvelmans H, Seaman J, Veeken H, de Wit S, Davidson RN.

    Bull World Health Organ. 2001;79(5):388-93.PMID: 11417033 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    [7th Conference on Retroviruses and Opportunistic Infections]

    De Wit S.

    Rev Med Brux. 2000 Dec;21(6):A521-3. French. No abstract available. PMID: 11194504 [PubMed - indexed for MEDLINE]Related articles

    48.

    In vitro activity of gemifloxacin compared with other antimicrobial agents against recent clinical isolates of streptococci.

    Ieven M, Goossens W, De Wit S, Goossens H.

    J Antimicrob Chemother. 2000 Apr;45 Suppl 1:51-3.PMID: 10824033 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Update on highly active antiretroviral therapy: progress and strategies.

    Clumeck N, De Wit S.

    Biomed Pharmacother. 2000 Feb;54(1):7-12. Review.PMID: 10721456 [PubMed - indexed for MEDLINE]Related articles

    50.

    Efficacy and safety of trazodone versus clorazepate in the treatment of HIV-positive subjects with adjustment disorders: a pilot study.

    De Wit S, Cremers L, Hirsch D, Zulian C, Clumeck N, Kormoss N.

    J Int Med Res. 1999 Sep-Oct;27(5):223-32.PMID: 10689628 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...